{"id":"W4409758329","doi":"10.1182/bloodadvances.2024015490","title":"Characterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatment","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Janssen Pharmaceuticals; Chugai Pharmaceutical; Samsung; Grifols; Swedish Orphan Biovitrum; BioCryst; Apellis Pharmaceuticals; Argenx; Incyte; Novo Nordisk; Sanofi; Celgene; AstraZeneca; Alexion Pharmaceuticals; Pfizer; Amgen","keywords":"Eculizumab; Medicine; Paroxysmal nocturnal hemoglobinuria; Anemia; Population; Hemolysis; Internal medicine; Hemoglobinuria; Gastroenterology; Hemolytic anemia; Immunology; Complement system; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001393551,0.0003164022,0.0005860081,0.0001971509,0.0001358545,0.00002236395,0.0002747842,0.0001022432,0.0003869422],"category_scores_gemma":[0.00009359155,0.0002089346,0.0001450926,0.0002865946,0.0001245259,0.0001081147,0.00005002407,0.0001314268,0.0001030158],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000870703,"about_ca_system_score_gemma":0.0001701248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000847726,"about_ca_topic_score_gemma":0.0002447576,"domain_scores_codex":[0.9979796,0.0002514709,0.0006288937,0.0006529596,0.00006837468,0.0004187179],"domain_scores_gemma":[0.9988014,0.0003901967,0.0001978258,0.000532412,0.0000466738,0.00003149153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.05685101,0.0187774,0.3963154,0.001485146,0.006837782,0.001631583,0.003124463,0.0003234938,0.1136207,0.003091481,0.0004719883,0.3974695],"study_design_scores_gemma":[0.1026277,0.02087841,0.2944177,0.01094821,0.00241911,0.0001595457,0.008388878,0.00003037559,0.3211176,0.0004447186,0.2358075,0.002760203],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99111,0.005051209,0.00005665805,0.0003216692,0.00031893,0.0009811517,0.00007196627,0.0001143485,0.001974107],"genre_scores_gemma":[0.997067,0.0008287166,0.0002051709,0.0001929275,0.00002821263,0.0003417762,0.0001231307,0.00001748302,0.0011956],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3947093,"threshold_uncertainty_score":0.8520105,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01191389438309478,"score_gpt":0.2782307819318245,"score_spread":0.2663168875487297,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}